Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering the human placenta: Advances in modeling placental function.

Placenta·2026
Same author

Selective capture and digital counting of intact HIV pseudovirus using designer DNA nets, tethered motion, and photonic resonator interferometric scattering microscopy.

APL bioengineering·2026
Same author

LDL-binding IL-10 reduces vascular inflammation in atherosclerotic mice.

Nature biomedical engineering·2026
Same author

Light-induced extracellular vesicle and particle adsorption.

Nature methods·2025
Same author

Migrasomes, Matrix-Bound Nanovesicles, and More: Messengers in the Matrix.

Proteomics·2025
Same author

Deep autoencoder as an interpretable tool for Raman spectroscopy investigation of chemical and extracellular vesicle mixtures.

Biomedical optics express·2024
Same journal

A human-specific genetic modifier reconfigures large-scale cortical network dynamics underlying behavioral performance.

bioRxiv : the preprint server for biology·2026
Same journal

<i>Staphylococcus aureus</i> uses a eukaryotic-like uridyltransferase to make UDP-GlcNAc for cell wall synthesis.

bioRxiv : the preprint server for biology·2026
Same journal

Dynamic redistribution of eIF4F controls cap-dependent translation initiation.

bioRxiv : the preprint server for biology·2026
Same journal

When does additional information improve accuracy of RNA secondary structure prediction?

bioRxiv : the preprint server for biology·2026
Same journal

Normative brain-state trajectories reveal deviation from healthy aging in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same journal

Noradrenergic infraslow rhythm during sleep is the critical link between heart-rate dynamics and memory consolidation.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria
09:56

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria

Published on: October 13, 2021

4.6K

Bioreactor-Enabled Extracellular Vesicle Production for Downstream Functional Engineering.

Thaddeus L Tripp, Karina Vasile, Massimo Terrizzi

    Biorxiv : the Preprint Server for Biology
    |December 15, 2025
    PubMed
    Summary
    This summary is machine-generated.

    High-density bioreactors significantly increase extracellular vesicle (EV) production and enable efficient engineering for therapeutic applications. These scalable systems overcome limitations of traditional cell cultures, advancing EV-based drug delivery.

    More Related Videos

    Author Spotlight: The Production of Recombinant Proteins
    05:19

    Author Spotlight: The Production of Recombinant Proteins

    Published on: June 30, 2023

    9.6K
    Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
    08:50

    Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

    Published on: August 16, 2024

    1.3K

    Related Experiment Videos

    Last Updated: Jun 5, 2026

    Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria
    09:56

    Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria

    Published on: October 13, 2021

    4.6K
    Author Spotlight: The Production of Recombinant Proteins
    05:19

    Author Spotlight: The Production of Recombinant Proteins

    Published on: June 30, 2023

    9.6K
    Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
    08:50

    Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

    Published on: August 16, 2024

    1.3K

    Area of Science:

    • Biotechnology
    • Cell Biology
    • Nanomedicine

    Background:

    • Extracellular vesicles (EVs) show therapeutic promise but face challenges in clinical translation due to low production yields and inefficient engineering.
    • Current methods using standard flask cultures limit scalability and downstream modification of EVs.
    • There is a critical need for high-density bioreactor systems for robust EV production and versatile post-isolation engineering.

    Purpose of the Study:

    • To systematically compare EV production and engineerability across different culture systems: flask, membrane bioreactor, and hollow-fiber bioreactor.
    • To evaluate the scalability, resource efficiency, and translational feasibility of bioreactor-derived EVs.
    • To demonstrate the potential of bioreactor-produced EVs for advanced drug delivery applications through post-production engineering.

    Main Methods:

    • Comparative analysis of EV production using nanoparticle tracking analysis, immunoblotting, and transmission electron microscopy.
    • Proteomic analysis to confirm canonical EV phenotypes and assess translational potential.
    • Demonstration of novel EV engineering techniques: cargo-loading via EV-micelle hybridization and surface modification via micelle-carried molecule post-insertion.

    Main Results:

    • Hollow-fiber bioreactors yielded significantly higher EV concentrations with reduced medium consumption compared to flask cultures.
    • Bioreactor-derived EVs maintained essential phenotypes and demonstrated high engineerability for therapeutic modifications.
    • Novel EV engineering methods were successfully applied to bioreactor-produced EVs, requiring only minimal EV quantities.

    Conclusions:

    • Bioreactor platforms, particularly hollow-fiber and membrane-based systems, overcome throughput limitations of conventional EV production methods.
    • These scalable bioreactors produce engineerable EVs suitable for advanced drug delivery applications.
    • The study establishes bioreactors as translation-oriented systems for enhanced EV production and therapeutic development.